Pfizer Canada Schizophrenia or Bipolar Disorder Research Award (Grant)


Eligible Areas of Research: The focus of your research proposal must be in line with any of the following areas of research:

  • Research on cognitive function in schizophrenia or bipolar disorder
  • Investigating the effects of ziprasidone on cognition, functional outcomes and/or course of illness
  • Investigating the efficacy and safety of switching to ziprasidone
  • Investigating the mechanism of action of antipsychotic drugs on metabolic syndrome risk factors
  • Research on optimizing adherence to antipsychotic medication
  • Optimizing treatment with ziprasidone in patients with suboptimal efficacy
  • Pharmacogenomic research

About funding: This award (grant) is up to $100,000. Award funds are intended to be operating grants and must contribute towards the direct costs of the research program or project for which the funds are granted. Please note that the budget must be inclusive of institutional overhead where applicable; this amount shall not exceed 20% of the grant application budget. Please note that applicants may not receive a salary, a stipend, or an honorarium from the Pfizer Psychiatry Research Award.